Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02467972
Other study ID # CEPFCF194 CEPFCF18
Secondary ID CONEP BrasilCONE
Status Completed
Phase N/A
First received June 3, 2015
Last updated June 15, 2015
Start date April 2012
Est. completion date December 2012

Study information

Verified date June 2015
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ministry of Health
Study type Interventional

Clinical Trial Summary

The addition of fructans or unripe banana flour to frozen meals can change the hormonal parameters related to hunger and satiety, improve the bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR). The inulin no can change bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR)


Description:

Non-transmissible chronic diseases have been constantly related to the consumption of diets with inadequate nutrient input; at the same time, the ingestion of unavailable carbohydrates have presented an inverse relationship with the risk for these diseases. Among these carbohydrates is inulin, a fructan considered as a prebiotic and the unripe banana flour, rich in resistant starch, which may contribute to the intestinal health.

This study evaluated the effect of regular intake of frozen soups added functional ingredients (fructans and unripe banana flour) by heath volunteers, about gastrointestinal hormones, satiety and bowel movements.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date December 2012
Est. primary completion date August 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- good health condition

Exclusion Criteria:

- history of renal or gastrointestinal disease

- hyperthyroidism

- diabetes, nor parents with diabetes

- for women: not pregnant, breastfeeding or using hormonal therapy

- using any drug that might affect the digestion of food and absorption (antibiotics, laxatives)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Ready-to-eat frozen soups added unripe banana flour
Ready-to-eat frozen soups added unripe banana flour (18 portions; 3 times/week)
Ready-to-eat frozen soups added maltodextrin
Ready-to-eat frozen soups added maltodextrin (18 portions; 3 times/week)
Ready-to-eat frozen soups added inulin
Ready-to-eat frozen soups added inulin (18 portions; 3 times/week)
Ready-to-eat frozen soups added nisin
Ready-to-eat frozen soups added nisin (18 portions; 3 times/week)

Locations

Country Name City State
Brazil Faculty of Pharmaceutical Sciences USP Sao Paulo

Sponsors (3)

Lead Sponsor Collaborator
University of Sao Paulo Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in hormonal parameters related to hunger and satiety. Changes in satiety measured by specific hormones kit 6 weeks No
Primary Change in bowel function Changes measured by GSRS and daily questionnaires 6 weeks No
Primary Change in colonic bacteria population Changes measured by microbiological analysis by r16SDNA sequencing 6 weeks No
Primary Change in satiety Changes in satiety measured by Visual Analogue Scale questionnaire. 6 weeks No
Secondary Change in biochemical parameters Changes measured by biochemical kit 6 weeks No
See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4